IMCR
Immunocore Holdings plc American Depositary Shares
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Immunocore (IMCR) Stock: Buy, Sell, or Hold?
$32.38
+0.65 (+2.05%)
â˛
5d:
+7.83%
30d:
+11.5%
90d:
-6.79%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (87%)
Quality Score
53/100
Position
FAIR
30-Day Fair Range
$28.97 â $31.43
Position: FAIR
Forward P/E & Valuation
-32.6x
Next 12M consensus est.
Wall Street Target
$58.33
+80.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$28.12 / $32.72
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: IMCR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When IMCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IMCR is currently trading at $32.38, which is considered fair relative to its 30-day fair value range of $28.97 to $31.43.
Technical Outlook: Technically, IMCR is in a downtrend. The price is approaching resistance at $32.72. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IMCR scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $58.33 (+80.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMCR is in a downtrend. The price is approaching resistance at $32.72. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IMCR scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $58.33 (+80.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$28.97 -
$31.43
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
Trading Range & Key Levels
30-Day Trading Range
$28.97 -
$31.43
Current vs Trading Range
FAIR
Support Level
$28.12
Resistance Level
$32.72
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (69/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 80.2% below Wall St target ($58.33)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-32.55
Wall Street Target
$58.33
(+80.2%)
Revenue Growth (YoY)
-1.4%
Earnings Growth (YoY)
150.0%
Profit Margin
-7.5%
Share IMCR Analysis
Share this live IMCR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 11, 2026 9:06 AM ET
Data refreshes hourly during market hours. Next update: 10:06 AM
Data refreshes hourly during market hours. Next update: 10:06 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$978 | 37 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 43 HOLD |
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
21 analysts |
$650 | 36 SELL |
|
NAMS
NewAmsterdam Pharma CompâĻ |
STRONG BUY
16 analysts |
$50 | 49 HOLD |
|
CGEM
Cullinan Oncology LLC |
STRONG BUY
12 analysts |
$35 | 57 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IMCR Research Pages
